Acadian Asset Management LLC decreased its position in Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) by 82.9% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 86,072 shares of the business services provider's stock after selling 416,145 shares during the period. Acadian Asset Management LLC owned about 0.26% of Cross Country Healthcare worth $1,280,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Longfellow Investment Management Co. LLC bought a new stake in shares of Cross Country Healthcare during the 1st quarter worth approximately $59,000. AlphaQuest LLC raised its stake in shares of Cross Country Healthcare by 324.6% during the 1st quarter. AlphaQuest LLC now owns 8,297 shares of the business services provider's stock worth $124,000 after purchasing an additional 6,343 shares in the last quarter. Nomura Holdings Inc. bought a new stake in shares of Cross Country Healthcare during the 1st quarter worth approximately $232,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Cross Country Healthcare by 4.7% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 18,386 shares of the business services provider's stock worth $334,000 after purchasing an additional 817 shares in the last quarter. Finally, Vident Advisory LLC bought a new stake in shares of Cross Country Healthcare during the 1st quarter worth approximately $392,000. Institutional investors own 96.03% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities research analysts recently weighed in on CCRN shares. Wall Street Zen upgraded Cross Country Healthcare to a "hold" rating in a research note on Saturday, August 9th. Barrington Research restated a "market perform" rating and issued a $18.61 price target on shares of Cross Country Healthcare in a research note on Tuesday, June 17th. Six equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Cross Country Healthcare has a consensus rating of "Hold" and an average target price of $17.93.
Get Our Latest Report on Cross Country Healthcare
Cross Country Healthcare Price Performance
NASDAQ CCRN traded down $0.12 on Friday, reaching $13.54. The stock had a trading volume of 690,296 shares, compared to its average volume of 408,540. The firm has a fifty day moving average of $13.23 and a two-hundred day moving average of $13.70. Cross Country Healthcare, Inc. has a 1-year low of $9.58 and a 1-year high of $18.33. The company has a market cap of $443.57 million, a P/E ratio of -52.08, a price-to-earnings-growth ratio of 8.08 and a beta of 0.38.
Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The business services provider reported ($0.01) EPS for the quarter, missing analysts' consensus estimates of $0.07 by ($0.08). Cross Country Healthcare had a negative net margin of 0.70% and a positive return on equity of 1.72%. The firm had revenue of $274.07 million during the quarter, compared to analyst estimates of $292.67 million. Research analysts predict that Cross Country Healthcare, Inc. will post 0.53 EPS for the current fiscal year.
About Cross Country Healthcare
(
Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Recommended Stories

Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.